Drug firm Novartis India today said its net profit rose by 74.94 per cent to Rs 40.50 crore for the third quarter ended December 31, 2010, over the same period previous fiscal.
The company had posted a net profit of Rs 23.15 crore in the same period last fiscal, Novartis India said in a filing to the Bombay Stock Exchange (BSE).
Net sales of the company for the third quarter ended December 31, 2010 rose to Rs 184.04 crore from Rs 160.46 crore in the same period previous fiscal.
Novartis India is Indian arm of Swiss pharma giant Novartis International AG, based in Basel, Switzerland.
Shares of Novartis India today closed at Rs 608.55 on the BSE, down 1.08 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app